Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study
Crossref DOI link: https://doi.org/10.1038/bmt.2015.281
Published Online: 2015-11-23
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, M
Sun, J
Zhang, Y
Huang, F
Zhou, H
Fan, Z
Xuan, L
Yu, G
Guo, X
Dai, M
Feng, R
Liu, Q
Text and Data Mining valid from 2015-11-23
Version of Record valid from 2015-11-23
Article History
First Online: 23 November 2015
Competing interests
: The authors declare no conflict of interest.